MBRX

Moleculin Biotech Share Price - MBRX

3.8801
0.0101 (0.26%)
Upgrade to Real-Time
Afterhours (Closed)
3.8801

Low
0.6526

52 Week Range

High
8.78

Best deals to access real time data!
USA CHART Trader
Monthly Subscription
for only
US$30.66
North American Extreme
Monthly Subscription
for only
US$104.50
USA Small Cap Basic
Monthly Subscription
for only
US$33.03
VAT not included
Stock Name Stock Symbol Market Stock Type
Moleculin Biotech Inc MBRX NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.0101 0.26% 3.8801 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.89 3.81 3.89 3.86 3.87
Bid Price Ask Price Spread News
3.75 3.97 0.22 - -
Trades Stocks Traded VWAP Financial Volume Average Volume 52 Week Range
891 145,991 US$ 3.86 US$ 563,458 289,557 0.6526 - 8.78
Last Trade Type Quantity Price Currency
16:17:15 formt 100 US$ 3.8801 USD

Moleculin Biotech Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 110.37M 28.44M 27.87M US$ - US$ - -1.73 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- US$ - - - 5.30%

more financials information »

Moleculin Biotech News

Date Time Source News Article
6/09/202115:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
6/09/202115:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/28/202115:38Edgar (US Regulatory)Current Report Filing (8-k)
5/28/202115:34Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)
5/25/202108:14Seeking AlphaMoleculin kicks off phase 1b/2 annamycin cancer trial
5/25/202108:05PR Newswire (US)Moleculin Commences Phase 1b/2 Clinical Trial of Annamycin..
5/25/202108:02Edgar (US Regulatory)Current Report Filing (8-k)
5/13/202115:19Edgar (US Regulatory)Current Report Filing (8-k)
5/12/202106:46Seeking AlphaMoleculin Biotech EPS beats by $0.03
5/12/202106:36Edgar (US Regulatory)Current Report Filing (8-k)
5/12/202106:35PR Newswire (US)Moleculin Reports First Quarter 2021 Financial Results and..
5/12/202106:31Edgar (US Regulatory)Quarterly Report (10-q)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MBRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.733.993.70073.87354,3140.15014.02%
1 Month3.253.993.203.67288,7560.630119.39%
3 Months4.254.773.123.951,210,689-0.3699-8.7%
6 Months0.80218.780.76023.682,381,3783.08383.74%
1 Year1.158.780.65262.382,331,9562.73237.4%
3 Years1.838.780.3231.841,784,4272.05112.03%
5 Years7.388.780.3231.911,384,626-3.50-47.42%

Moleculin Biotech Description

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with its focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.
Your Recent History
NASDAQ
MBRX
Moleculin ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210614 06:41:15